Анализ удовлетворенности лекарственной терапией гипертрофии предстательной железы у пациентов пожилого и старческого возраста. / Popov, S.V.; Huseynov, R.H.; Sivak, K.V.; Treshkin, E.V.; Sengirbaev, D.I.; Perepelitsa, V.V.; Bunenkov, N.V.; Llyavin, T.A.
In: УРОЛОГИЯ, Vol. 2025, No. 2, 2025, p. 83-87.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Анализ удовлетворенности лекарственной терапией гипертрофии предстательной железы у пациентов пожилого и старческого возраста
AU - Popov, S.V.
AU - Huseynov, R.H.
AU - Sivak, K.V.
AU - Treshkin, E.V.
AU - Sengirbaev, D.I.
AU - Perepelitsa, V.V.
AU - Bunenkov, N.V.
AU - Llyavin, T.A.
N1 - Export Date: 05 February 2026; Cited By: 0; Correspondence Address: T.A. Llyavin; GBUZ «City Hospital Saint Luka», St. Petersburg, st. Cast iron, 46, 194044, Russian Federation; email: tatianalelyavina@mail.ru
PY - 2025
Y1 - 2025
N2 - Age is a non-modifiable risk factor for the development of benign prostatic hyperplasia (BPH). The algorithm of drug treatment of BPH is well known. From the perspective of modern patient-oriented medicine, when evaluating the efficiency of treatment, the subjective assessment by the patient, including satisfaction with the therapy, are important. Predictors of patients' dissatisfaction with drug therapy and low adherence to treatment are the persistence of lower urinary tract symptoms, especially nocturia, as well as the presence of erectile dysfunction. It is recommended to integrate the evaluation of treatment satisfaction into routine clinical practice, which will improve the quality of medical care. We have presented a literature review of satisfaction with drug therapy in elderly and senile patients with BPH, according to modern literature. The literature sources for 2018-2023 in the databases Springer, PubMed, eLibrary, Cyberleninca in Russian and English on the subjective assessments by patients of the older age of the treatment of BPH were analyzed. © 2025, Bionika Media Ltd.. All rights reserved.
AB - Age is a non-modifiable risk factor for the development of benign prostatic hyperplasia (BPH). The algorithm of drug treatment of BPH is well known. From the perspective of modern patient-oriented medicine, when evaluating the efficiency of treatment, the subjective assessment by the patient, including satisfaction with the therapy, are important. Predictors of patients' dissatisfaction with drug therapy and low adherence to treatment are the persistence of lower urinary tract symptoms, especially nocturia, as well as the presence of erectile dysfunction. It is recommended to integrate the evaluation of treatment satisfaction into routine clinical practice, which will improve the quality of medical care. We have presented a literature review of satisfaction with drug therapy in elderly and senile patients with BPH, according to modern literature. The literature sources for 2018-2023 in the databases Springer, PubMed, eLibrary, Cyberleninca in Russian and English on the subjective assessments by patients of the older age of the treatment of BPH were analyzed. © 2025, Bionika Media Ltd.. All rights reserved.
KW - benign prostatic hyperplasia
KW - drug therapy
KW - elderly patients
KW - satisfaction with treatment
KW - age
KW - aged
KW - human
KW - male
KW - patient satisfaction
KW - prostate hypertrophy
KW - very elderly
KW - Age Factors
KW - Aged
KW - Aged, 80 and over
KW - Humans
KW - Male
KW - Patient Satisfaction
KW - Prostatic Hyperplasia
U2 - 10.18565/urology.2025.2.83-87
DO - 10.18565/urology.2025.2.83-87
M3 - статья
VL - 2025
SP - 83
EP - 87
JO - УРОЛОГИЯ
JF - УРОЛОГИЯ
SN - 1728-2985
IS - 2
ER -
ID: 149035960